Show simple item record

dc.contributor.authorMilojkovic, D
dc.contributor.authorReynolds, CJ
dc.contributor.authorSandoval, DM
dc.contributor.authorPieper, FP
dc.contributor.authorLiu, S
dc.contributor.authorPade, C
dc.contributor.authorGibbons, JM
dc.contributor.authorMcKnight, A
dc.contributor.authorLoaiza, S
dc.contributor.authorPalanicawander, R
dc.contributor.authorInnes, AJ
dc.contributor.authorClaudiani, S
dc.contributor.authorApperley, JF
dc.contributor.authorAltmann, DM
dc.contributor.authorBoyton, RJ
dc.date.accessioned2023-10-19T11:04:54Z
dc.date.available2022-12-02
dc.date.available2023-10-19T11:04:54Z
dc.date.issued2023
dc.identifier.issn0887-6924
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/91431
dc.format.extent244 - 247
dc.relation.ispartofLEUKEMIA
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.titleCOVID-19 vaccine boosted immunity against Omicron in chronic myeloid leukemia patients treated with tyrosine kinase inhibitorsen_US
dc.typeArticleen_US
dc.identifier.doi10.1038/s41375-022-01787-8
pubs.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000900048000001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue1en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume37en_US
qmul.funderThe Durability of immune Responses to vaccination against SARS-CoV-2 and its Variants.::Medical Research Councilen_US
qmul.funderThe Durability of immune Responses to vaccination against SARS-CoV-2 and its Variants.::Medical Research Councilen_US
qmul.funderThe Durability of immune Responses to vaccination against SARS-CoV-2 and its Variants.::Medical Research Councilen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States